Alyeska Investment Group’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-90,201
Closed -$3.48M 828
2026
Q1
$3.48M Sell
90,201
-1,136,771
-93% -$47.2M 0.01% 512
2025
Q4
$57M Sell
1,226,972
-66,035
-5% -$3.18M 0.16% 162
2025
Q3
$63.5M Sell
1,293,007
-70,054
-5% -$3.66M 0.19% 143
2025
Q2
$70.5M Buy
+1,363,061
New +$55.1M 0.25% 117

Other funds holding HNGE

Alyeska Investment Group's HNGE Position: Q2 2026 in Review

Alyeska Investment Group sold out of Hinge Health (HNGE) in Q2 2026, closing a stake of 90,201 shares — an estimated $3.48M sold.

Alyeska Investment Group first reported a position in HNGE in Q2 2025 and held it in 4 quarters. The position peaked at $70.5M in Q2 2025. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Alyeska Investment Group reported no remaining Hinge Health position as of Q2 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 90,201 Hinge Health shares in Q2 2026, an estimated $3.48M.
  • Alyeska Investment Group first reported a position in Hinge Health in Q2 2025 and held it in 4 quarters.
  • Alyeska Investment Group's Hinge Health position peaked at $70.5M in Q2 2025.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.